<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="366851">
  <stage>Registered</stage>
  <submitdate>5/08/2014</submitdate>
  <approvaldate>21/08/2014</approvaldate>
  <actrnumber>ACTRN12614000889651</actrnumber>
  <trial_identification>
    <studytitle>Comparison of desogestrel and levonorgestrel releasing intrauterine device in terms of menstrual pattern, side effects and patient satisfaction in postpartum contraception </studytitle>
    <scientifictitle>Comparison of desogestrel and levonorgestrel releasing intrauterine device in terms of menstrual pattern, side effects and patient satisfaction in postpartum contraception </scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Postpartum contraception</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Contraception</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Arm 1: Desogestrel 75 mcg/day orally 28 days, continously, observation for 12 months.
Arm 2: Levonorgestrel releasing intrauterine device applied by the physician which releases 20mcg levonorgestrel/day into the endometrial cavity, observation for 12 months.
</interventions>
    <comparator>Two contraceptive methods will be compared. (Desogestrel orally versus levonorgestrel releasing intrauterine device)</comparator>
    <control>Active</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Primary outcome is the menstrual pattern of the patient 
Patients willing to participate into the study will be given a calender and they will be asked to mark the days with spotting, days with bleeding or days with heavy bleeding each month. </outcome>
      <timepoint>Third month, sixth month and 1st year after the method was started</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Side effects of desogestrel or levonorgestrel releasing intrauterine device.
Possible side effects will be asked to the patiens and side effect notification forms will be filled up by the physician.
Irregular bleeding
Spotting
Headache
Nausea
Breast tenderness
Depressive symptoms
Acne
Amenorrhea
Weight gain
Mood changes
Vaginal discharge
Pelvic infection
Others</outcome>
      <timepoint>Third month, sixth month and 1st year after the method was started</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Patient satisfaction
Patients will be asked if they are satisfied with the method and if they wish to continue. If they are not pleased the reason will be asked and noted. Special  query forms are prepared for the visits.  </outcome>
      <timepoint>Third month, sixth month and 1st year after the method was started</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients who were prescribed oral desogestrel or who were applied levonorgestrel releasing intrauterine device for postpartum contraception
Six weeks passed after vaginal birth and 8 weeks passed after cesarean section
Patients giving consent for the participation to the study</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>History of acute artery or vein thrombosis
6 months passed after the delivery
Women with acute or chronic liver disease, diabetes, hypertension or renal disease
Women having postpartum depressive symptoms
Patients who won't give consent for the participation</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>For the target sample size power analyses was performed. For a bleeding difference of 30%, 47 patients in each group are requested with a power of 80%. Regarding a drop out rate of at least %20, 56 patients in each group are planned for recruiment. </statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/09/2014</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>112</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Ankara</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Individual</primarysponsortype>
    <primarysponsorname>Mine Kiseli</primarysponsorname>
    <primarysponsoraddress>Ufuk University Medical School Mevlana Bulvari No:86 06540 Balgat Ankara</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname>No funding exist</fundingname>
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This observational study aims to investigate and compare the menstrual bleeding patterns in patients taking desogestrel or levonorgestrel releasing intrauterine device as postpartum contraceptive method. Secondary purpose is comparing patient satisfaction and side effects concerning these two contraceptive methods. Follow up time will be one year.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ankara University Faculty of Medicine Ethics Committee</ethicname>
      <ethicaddress>Ankara University Faculty of Medicine, Morfoloji Yerleskesi,  06100 Sihhiye/ Ankara</ethicaddress>
      <ethicapprovaldate>13/01/2014</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>15/05/2013</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Mine Kiseli</name>
      <address>Ufuk University Faculty of Medicine, Department of Obstetrics and Gynecology
Mevlana Bulvari No:86 
06540 Balgat/ Ankara </address>
      <phone>+90 312 2044318 (Ankara, Turkey)</phone>
      <fax />
      <email>minekiseli@gmail.com</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Mine Kiseli</name>
      <address>Ufuk University Faculty of Medicine, Department of Obstetrics and Gynecology
Mevlana Bulvari No:86
06540 Balgat/ Ankara </address>
      <phone>+90 312 2044318 (Ankara/ Turkey)</phone>
      <fax />
      <email>minekiseli@gmail.com</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Mine Kiseli</name>
      <address>Ufuk University Faculty of Medicine, Department of Obstetrics and Gynecology
Mevlana Bulvari No:86 
06540 Balgat/ Ankara </address>
      <phone>+90 312 2044318 (Ankara/ Turkey)</phone>
      <fax />
      <email>minekiseli@gmail.com</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>